CME Presentations

EoE


Presentations


Speakers

  • Matthew Greenhawt, MD, MBA, MSc

    Matthew Greenhawt, MD, MBA, MSc

    Matthew Greenhawt, MD, MBA, MSc

    Professor, Department of Pediatrics Section of Allergy and Immunology

    Matthew Greenhawt, MD, MBA, MSc, is a professor in the Department of Pediatrics Section of Allergy and Immunology at Children’s Hospital Colorado and the University of Colorado School of Medicine and is the director for the Children’s Hospital Colorado Food Challenge and Research Unit. Dr. Greenhawt’s research interests include shared decision-making, food allergy cost-effectiveness and comparative effectiveness research, food-allergic diseases health services research, primary/secondary prevention and treatment of food allergy, and food allergy public policy. He has authored several peer-reviewed articles, abstracts, and book chapters. He is the senior associate editor for the Annals of Allergy, Asthma and Immunology, and a member of the Joint Taskforce of Allergy Practice Parameters.
  • Bethany Doerfler, MS, RDN

    Bethany Doerfler, MS, RDN

    Bethany Doerfler, MS, RDN

    Clinical Research Dietitian

    Bethany Doerfler, MS, RDN, is a clinical research dietitian with more than 22 years of experience who specializes in lifestyle management of a range of digestive diseases including GERD, motility disorders and eosinophilic digestive diseases. She currently practices as part of a multidisciplinary team in the Digestive Health Center at Northwestern Medicine. Over the past years, she has collaborated with Northwestern Colleagues investigating the role of modifying dietary triggers in the treatment of Eosinophilic disorders, funded by Consortium of Eosinophilic Disease Researchers (CEGIRS). Bethany is a founding member of the Dietitians in Gastrointestinal Disorders (DIGID) upper esophageal working group and has lectured on digestive health to public and academic audiences within the U.S.
  • Ikuo Hirano, MD

    Ikuo Hirano, MD

    Ikuo Hirano, MD

    Professor of Medicine, Division of Gastroenterology and Hepatology

    Ikuo Hirano, MD, is a Professor of Medicine at Northwestern University Feinberg School of Medicine. Dr. Hirano took a faculty position at the West Roxbury VA Medical Center and Harvard Medical School working in esophageal swallowing physiology before coming to Northwestern. He is a site principal investigator for the National Institutes of Health (NIH) supported Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR). Dr. Hirano has written over 200 scientific papers and textbook chapters on esophageal and swallowing disorders. For the past two decades, he has focused his clinical and academic interests on eosinophilic esophagitis/gastroenteritis, and he has authored several society guidelines on the management of these increasingly recognized disorders.

CME Information

Global LogoPQH Logo

Eosinophilic Esophagitis: Guidelines and Emerging Evidence for Effective Management Strategies

This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the Asthma and Allergy Foundation of America (AAFA).

ACKNOWLEDGEMENT

This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme, and Takeda Pharmaceuticals U.S.A., Inc.

LIVE DATE OF RELEASE

Wednesday, March 8 from 4:30-5:30pm ET.

TARGET AUDIENCE

Gastroenterologists, allergists, immunologists, pediatric gastroenterologists, pediatric allergists/immunologists, specialty NPs/PAs, and interprofessional teams.

STATEMENT OF NEED/PROGRAM OVERVIEW

The signs and symptoms of eosinophilic esophagitis (EoE) are frequently missed or misinterpreted. In addition, treatment options are limited and mainly consist of agents used off-label for EoE. While treatment guidelines were recently updated, strategies remain limited due to a lack of data and few effective medical and surgical treatments. Novel topical corticosteroid formulations and treatments that target the underlying pathophysiologic drivers of EoE are in the late stages of clinical development. These agents will allow for a more data-driven approach to the management of EoE and prevent cumulative exposure to systemic steroids in patients who often suffer from other allergic comorbidities.

Join a panel of expert clinicians from various specialties for an in-depth discussion on the diagnosis and management of EoE. Panelists will discuss how to recognize the symptoms of EoE across a variety of patient ages to facilitate an early diagnosis. The activity will also review emerging data on new, more-efficient, targeted agents that, as they become available, could help minimize patient suffering and decrease the risk of tissue remodeling and development of serious complications related to EoE.

Do you have patients who could benefit from related education on the management of EoE and associated side effects? Direct your patients to MedLive.com to access the related patient-education activity, "Eating Without Pain: Partnership for Effective Management."

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:
  • Describe the clinical presentations of EoE in infants, toddlers, older children, and adults
  • Apply the most recent AGA/JTF clinical guidelines regarding safety, efficacy, and appropriate clinical use of proton pump inhibitors (PPIs), topical corticosteroids, and elimination diets for the management of children, adolescents, and adults with EoE
  • Discuss the mechanisms of action, efficacy, and safety of novel corticosteroid formulations and emerging Th-2 targeted pharmacologic agents in clinical development for the management of EoE

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter Reported Financial Relationship
Ikuo Hirano, MD
Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Consulting Fee: Adare, Allakos, Arena Pharmaceuticals, Aslan AstraZeneca, BMS/Celgene/Receptos, Celldex, Sanofi/Regeneron, Esocap, Gossamer Bio, Lilly, Shire/Takeda, Parexel/Calyx
Contracted Research: Allakos, Arena, AstraZeneca, Bristol-Myers Squibb/Celgene, Sanofi/Regeneron, Shire/Takeda
Bethany Dofler, R.D
Senior Clinical Research Dietician
Northwestern Fienberg School of Medicine
Nothing to disclose
Matthew Greenhawt, MD
Director, Food Challenge and Research Unit
Children’s Hospital Colorado
Consulting Fee (e.g., Advisory Board): Aquestive, DBV Technologies, Sanofi/Regeneron, Nutricia, Novartis, Aquestive, Allergy Therapeutics, AstraZeneca, ALK-Abello, Prota
Honoraria: ImSci

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reported Financial Relationship
Rhys Williams, MSN, FNP-C, RN Nothing to disclose
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Carole Drexel Nothing to disclose
Eve Wilson Nothing to disclose
Caroline Laurendeau Nothing to disclose
Chuck Kulda- Patient Participant Nothing to disclose
Donna Taylor- Patient participant Other (Describe): In Studies Sponsored by: Covis Pharma, Regeneron


DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Technical Support:

For any technical issues or issues with your CME Certificate, please contact ClinicalSeriesLive.com at 877-394-1306 or at Support@ClinicalSeriesLive.com.